Isolagen^® is a biotechnology company 
     focused on developing emergent, novel
     skin and tissue rejuvenation
     technologies with broad potential in
     aesthetic and therapeutic markets.
 

August 14, 2008
Isolagen, Inc. Receives American Stock Exchange Notice Accepting Its Previously Submitted Plan of Compliance and Canceling the Delisting Hearing
 

Webcast Investor Conference Call Wednesday, August 6, 2008

August 5, 2008
Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy™ in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant